Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Using ctDNA to predict recurrence and response in colorectal cancer

Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA
Using ctDNA to predict recurrence and response in colorectal cancer ( Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA )
15 Jul 2019

Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer

Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer ( Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany )
15 Jul 2019

Treating HER2-mutant advanced biliary tract cancer with neratinib

Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
Treating HER2-mutant advanced biliary tract cancer with neratinib ( Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA )
15 Jul 2019

CAPTEM vs FOLFIRI as second-line treatment for mCRC patients

Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
15 Jul 2019

VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer

Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer ( Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan )
15 Jul 2019

TRIBE2: Latest data for patients with mCRC

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
TRIBE2: Latest data for patients with mCRC ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
15 Jul 2019

Entrectinib in NTRK-fusion positive gastrointestinal cancers

Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy
Entrectinib in NTRK-fusion positive gastrointestinal cancers ( Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy )
15 Jul 2019

Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer

Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Brest, Brest, France
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer ( Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Brest, Brest, France )
15 Jul 2019

Challenges in global cancer control

Prof Mary Gospodarowicz
Challenges in global cancer control ( Prof Mary Gospodarowicz )
12 Jul 2019

Implementing the Breast Health Global Initiative guidelines

Prof Benjamin Anderson
Implementing the Breast Health Global Initiative guidelines ( Prof Benjamin Anderson )
12 Jul 2019

Cancer care in Latin America

Dr Jean Rene Clemenceau
Cancer care in Latin America ( Dr Jean Rene Clemenceau )
12 Jul 2019

ASCO 2019 and vision for cancer control

Dr Eduardo Cazap, MD, PhD
ASCO 2019 and vision for cancer control ( Dr Eduardo Cazap, MD, PhD )
12 Jul 2019